This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Hikma Pharmaceuticals Governance Journey
Paine, Lynn Sharp; Srinivasan, Suraj; Yucaoglu, GamzeCase HBS-318108-EKnowledge and CommunicationThe case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company's 2017 AGM and reflecting on changes made over the previous year to address concerns expressed by proxy advisors andStarting at €8.20